NCT02189330 - A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood Samples | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

Tafamidis

20 mg of current commercial formulation.

DRUG

Tafamidis

12.2 mgA free acid tablet.

DRUG

Tafamidis

20 mg new soft gelatin capsule.

DRUG

Tafamidis

4 capsules of 20 mg tafamidis of current commercial formulation.

DRUG

Tafamidis

4 capsules of 12.2 mg tafamidis of free acid tablet..

Trial Locations (1)

Pfizer Investigational Site, Brussels